Format

Send to

Choose Destination
J Public Health Policy. 2016 May;37(2):149-59. doi: 10.1057/jphp.2016.6. Epub 2016 Feb 25.

Unhealthy marketing of pharmaceutical products: An international public health concern.

Author information

1
Department of Sociology, Lund University, Paradisgatan 5, Box 114, Lund, 211 00, Sweden.

Abstract

I consider the current state of pharmaceutical marketing vis-à-vis ethical and legal standards and advocate measures to improve it. There is abundant evidence of unethical or illicit marketing. It fuels growing concerns about undue corporate influence over pharmaceutical research, education, and consumption. The most extensive evidence of industry transgressions comes from the United States (US), where whistle-blowers are encouraged by financial rewards to help uncover illicit marketing and fraud. Outside the US increasing evidence of transgressions exists. Recently I have observed a range of new measures to align pharmaceutical marketing practices with ethical and legal standards. In the interest of public health, I highlight the need for additional and more profound reforms to ensure that information about medicines supports quality and resource-efficient care.

PMID:
26911654
DOI:
10.1057/jphp.2016.6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center